Literature DB >> 31350277

Heart failure risk predictions in adult patients with congenital heart disease: a systematic review.

Fei Wang1,2, Lee Harel-Sterling3, Sarah Cohen4, Aihua Liu2, James M Brophy2, Gilles Paradis1, Ariane J Marelli2.   

Abstract

To summarise existing heart failure (HF) risk prediction models and describe the risk factors for HF-related adverse outcomes in adult patients with congenital heart disease (CHD). We performed a systematic search of MEDLINE, EMBASE and Cochrane databases from January 1996 to December 2018. Studies were eligible if they developed multivariable models for risk prediction of decompensated HF in adult patients with CHD (ACHD), death in patients with ACHD-HF or both, or if they reported corresponding predictors. A standardised form was used to extract information from selected studies. Twenty-five studies met the inclusion criteria and all studies were at moderate to high risk of bias. One study derived a model to predict the risk of a composite outcome (HF, death or arrhythmia) with a c-statistic of 0.85. Two studies applied an existing general HF model to patients with ACHD but did not report model performance. Twenty studies presented predictors of decompensated HF, and four examined patient characteristics associated with mortality (two reported predictors of both). A wide variation in population characteristics, outcome of interest and candidate risk factors was observed between studies. Although there were substantial inconsistencies regarding which patient characteristics were predictive of HF-related adverse outcomes, brain natriuretic peptide, New York Heart Association class and CHD lesion characteristics were shown to be important predictors. To date, evidence in the published literature is insufficient to accurately profile patients with ACHD. High-quality studies are required to develop a unique ACHD-HF prediction model and confirm the predictive roles of potential risk factors. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cardiac risk factors and prevention; congenital heart disease; heart failure; systemic review

Year:  2019        PMID: 31350277     DOI: 10.1136/heartjnl-2019-314977

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  6 in total

1.  Application of Three-Dimensional Culture Method in the Cardiac Conduction System Research.

Authors:  Abhishek Mishra; Kishore B S Pasumarthi
Journal:  Methods Protoc       Date:  2022-06-14

2.  Recurrent disease progression networks for modelling risk trajectory of heart failure.

Authors:  Xing Han Lu; Aihua Liu; Shih-Chieh Fuh; Yi Lian; Liming Guo; Yi Yang; Ariane Marelli; Yue Li
Journal:  PLoS One       Date:  2021-01-06       Impact factor: 3.240

3.  Impact of COVID-19 on Medical Supply in Adults With Congenital Heart Disease.

Authors:  Steffen Akkermann; Tim Halling; Friederike Löffler; Ann S Silber-Peest; Tillmann Krüger; Stefan Bleich; Johann Bauersachs; Kai G Kahl; Mechthild Westhoff-Bleck
Journal:  Front Psychiatry       Date:  2022-03-17       Impact factor: 4.157

4.  Diagnostic Value of Abdominal B-Ultrasound for Congenital Heart Disease Complicated with Extracardiac Malformation in the Second Trimester of Pregnancy.

Authors:  Yanming Deng; Lili Zhan; Zhouli Yu; Jianfang Wan
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-07       Impact factor: 2.650

5.  Clinical Course Long After Atrial Switch: A Novel Risk Score for Major Clinical Events.

Authors:  Odilia I Woudstra; Tjitske E Zandstra; Rosanne F Vogel; Arie P J van Dijk; Hubert W Vliegen; Philippine Kiès; Monique R M Jongbloed; Anastasia D Egorova; Pieter A F M Doevendans; Thelma C Konings; Barbara J M Mulder; Michael W T Tanck; Folkert J Meijboom; Berto J Bouma
Journal:  J Am Heart Assoc       Date:  2021-02-22       Impact factor: 5.501

6.  Tuning and external validation of an adult congenital heart disease risk prediction model.

Authors:  Laurie W Geenen; Alexander R Opotowsky; Cara Lachtrupp; Vivan J M Baggen; Sarah Brainard; Michael J Landzberg; David van Klaveren; Hester F Lingsma; Eric Boersma; Jolien W Roos-Hesselink
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2022-01-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.